New Jersey: Dupixent (dupilumab) litigat… | DrugsMonitor.com

Dupixent (dupilumab) litigation in New Jersey (NJ): Consumer snapshot of claims themes, timing cues, and requesting help—not legal advice.

dupilumab, atopic dermatitis, asthma, ocular surface disease, keratitis, vision injury, New Jersey